Summary
This 8-K filing from CVS Health (CVS) on August 2, 2016, primarily announces the company's earnings for the second quarter ended June 30, 2016. While the filing itself is brief and mainly incorporates by reference a press release containing the detailed financial results, it signals the release of key operational and financial performance data for the period. Investors should refer to the attached press release (Exhibit 99.1) for comprehensive details on revenue, profitability, segment performance, and any forward-looking guidance provided by the company.
Key Highlights
- 1CVS Health announced its financial results for the second quarter ended June 30, 2016.
- 2The detailed earnings information is provided in a press release dated August 2, 2016, attached as Exhibit 99.1.
- 3This filing serves as notification of the earnings release.
- 4The information furnished in this report is not considered 'filed' with the SEC and will not be automatically incorporated into future SEC filings unless explicitly stated.
- 5Investors need to consult the referenced press release for specific financial metrics and performance analysis.
Frequently Asked Questions
The main purpose of this 8-K filing is to officially announce and provide access to CVS Health's earnings press release for the second quarter ended June 30, 2016.
The detailed financial results are contained within the press release dated August 2, 2016, which is attached as Exhibit 99.1 to this 8-K filing.
No, this 8-K filing does not contain new financial statements or disclosures directly. It incorporates by reference the press release which contains the financial results and related commentary.
The information furnished in this report is generally not considered 'filed' with the SEC and will not be automatically incorporated by reference into the Company's registration statements unless specifically stated otherwise by CVS Health.